orphan drug designation
Scope
Date
~
-
Bio & Pharma
Celltrion unveils cancer medicine to expand new drug pipelines
South Korea’s leading biosimilar drug developer Celltrion Inc. on Sunday unveiled an anticancer medicine to expand new pipelines and accelerat...
Apr 28, 2025 (Gmt+09:00)
-
Corporate strategy
Samsung seeks tech alliance with top US universities for robotics, AI, 6G
In an ambitious bid to shape the future of technology, Samsung Electronics Co. is launching a sweeping initiative to collaborate with elite North Am...
Apr 22, 2025 (Gmt+09:00)
-
Bio & Pharma
Celltrion expands footprint in Latin America with flagship oncology drugs
South Korea’s biopharmaceutical giant Celltrion Inc. has solidified its presence in South America after winning supply contracts for its flags...
Apr 17, 2025 (Gmt+09:00)
-
Bio & Pharma
Celltrion wins Australian approval for eye, bone disease biosimilars
Celltrion Inc. said Wednesday it has received regulatory approval from Australia’s Therapeutic Goods Administration (TGA) for three biosimilar...
Apr 10, 2025 (Gmt+09:00)
-
Leadership & Management
Samsung mobile chief fills leadership void in device division
Samsung Electronics Co. has appointed TM Roh, president and head of its mobile eXperience (MX) business, as the new chief of its device eXperience (...
Apr 02, 2025 (Gmt+09:00)
-
Bio & Pharma
Celltrion to sell autoimmune drug Stelara biosimilar at Costco in US
South Korea’s leading biosimilar drug developer Celltrion Inc. said on Monday it is set to sell Steqeyma, a biosimilar to autoimmune disease t...
Mar 25, 2025 (Gmt+09:00)
-
Bio & Pharma
SillaJen: First to use lab-grown human tissue to find best cancer drug dose
South Korean biotechnology firm SillaJen Inc. is pioneering a new approach to determine the best dose for a cancer drug combination in clinical tria...
Mar 18, 2025 (Gmt+09:00)
-
Mergers & Acquisitions
S.Korean grocery delivery platform Oasis at forefront to acquire TMON
South Korea’s grocery delivery platform Oasis Corp., which has been looking to expand its e-commerce market at home and abroad, is seeking to ...
Mar 05, 2025 (Gmt+09:00)
-
Bio & Pharma
Chong Kun Dang to build new plant for foray into biologics market
Chong Kun Dang Pharmaceutical Corp. is discussing building a research center and a plant in Siheung, about 30 kilometers southwest of Seoul, with th...
Feb 27, 2025 (Gmt+09:00)
-
Bio & Pharma
Celltrion wins EU approval for autoimmune disease treatment Avtozma
Celltrion Inc.’s Avtozma, a biosimilar to Roche’s autoimmune disease treatment Actemra, has won approval from the European Commission, f...
Feb 25, 2025 (Gmt+09:00)
-
Shipping & Shipbuilding
HD Korea Shipbuilding premieres nuclear-powered ship design
HD Korea Shipbuilding & Offshore Engineering Co. (HD KSOE), the parent of the world’s largest shipbuilder HD Hyundai Heavy Industries Co.,...
Feb 13, 2025 (Gmt+09:00)
-
Bio & Pharma
Lotte Biologics eyes first ADC CDMO order in 2025
SAN FRANCISCO -- Lotte Biologics Co., the drug consignment development and production unit of South Korean conglomerate Lotte Group, will seek to wi...
Jan 17, 2025 (Gmt+09:00)
-
IPOs
Celltrion seeks large-scale M&A in Q4, eyes 2027 Nasdaq debut
SAN FRANCISCO – South Korea’s leading biosimilar drug developer Celltrion Inc. seeks to acquire a domestic health food maker as early as...
Jan 16, 2025 (Gmt+09:00)
-
Bio & Pharma
SK Biopharmaceuticals, Eurofarma to set up AI epilepsy platform JV in US
South Korea’s SK Biopharmaceuticals Co. has signed a deal with Brazil’s Eurofarma Laboratórios S.A. to establish a joint venture ...
Jan 15, 2025 (Gmt+09:00)
-
Bio & Pharma
Yuhan’s lung cancer drug gets OK in Europe
Leclaza (ingredient: lazertinib), a new lung cancer treatment developed by South Korea’s Yuhan Corp. secured approval from the European Commis...
Dec 31, 2024 (Gmt+09:00)
-
Korean startups
CLO Virtual Fashion raises $35 mn
South Korea's 3D digital fashion solution startup CLO Virtual Fashion said on Monday it raised 50 billion won ($35 million).Atinum Investment Co. an...
Dec 16, 2024 (Gmt+09:00)
-
Bio & Pharma
Boryung, Lotus Pharma signs CDMO deal on anticancer injection
South Korea's Boryung Corp. said on Thursday it signed a contract with Lotus Pharmaceutical, a Taiwanese oncology firm, for contract development and...
Dec 12, 2024 (Gmt+09:00)
-
Bio & Pharma
SK Biopharm submits NDA of epilepsy drug to China
South Korea's SK Biopharmaceuticals Co. said on Tuesday it submitted the new drug application (NDA) for its flagship epilepsy drug Cenobamate to Chi...
Dec 05, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion’s Remsima on course to become Korea’s 1st blockbuster drug
Celltrion Inc.'s Remsima, the world’s first biosimilar monoclonal antibody, is on track to exceed 1 trillion won ($713 million) in sales this ...
Nov 25, 2024 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharma to move up launch of anti-obesity drug
South Korea’s Hanmi Pharmaceutical Co. announced on Thursday the launch of its anti-obesity drug candidate efpeglenatide has been rescheduled ...
Nov 21, 2024 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics wins $668 million CDMO deal with European pharma
Samsung Biologics Co., the world’s largest contract drugmaker, said on Wednesday it has signed two drug manufacturing contracts worth a combin...
Nov 20, 2024 (Gmt+09:00)
-
Shipping & Shipbuilding
Samsung Heavy gets AIP for wing sails of LNGC
South Korea's Samsung Heavy Industries said on Wednesday that it received Approval in Principle (AIP) for a liquefied natural gas (LNG) carrier equi...
Nov 20, 2024 (Gmt+09:00)
-
Batteries
South Korea approves Korea Zinc’s precursor as national core technology
South Korea has designated Korea Zinc Inc.'s precursor manufacturing process as a national core technology and advanced industrial technology, effec...
Nov 19, 2024 (Gmt+09:00)
-
Automobiles
Hyundai Motor unveils IONIQ 9 interior teaser
Hyundai Motor Co. unveiled a teaser image of the interior of its first large electric SUV, the IONIQ 9, on Wednesday.The IONIQ 9 is Hyundai’s ...
Nov 13, 2024 (Gmt+09:00)
-
Automobiles
Hyundai Motor designs the future of mobility in Irvine studio
IRVINE, Calif. -- White sneakers, gray nail polish, pink goggles and orange remote controls are not something visitors expect to see in car design s...
Nov 07, 2024 (Gmt+09:00)
-
Robotics
Hyundai Rotem to unveil unmanned firefighting robot
South Korea's Hyundai Rotem Co. unveiled on Thursday an unmanned firefighting robot designed to tackle fires in hazardous environments without riski...
Oct 31, 2024 (Gmt+09:00)
-
Bio & Pharma
ViGenCell obtains approval for HLA-B5801 genetic diagnostic kit for adverse reactions to gout treatment
ViGenCell, a company specializing in immunotherapy, announced on Friday that it has obtained approval from the Ministry of Food and Drug Safety (MFD...
Oct 25, 2024 (Gmt+09:00)
-
Electronics
Samsung Galaxy Z Fold Special Edition: slimmest, lightest of its kind
Samsung Electronics Co. said on Monday it is unveiling the Galaxy Z Fold Special Edition (SE) — the thinnest and lightest among the company&rs...
Oct 21, 2024 (Gmt+09:00)
-
Korean stock market
Korea Investment Management to list Global AI-based ASIC ETF
Korea Investment Management Co. said on Monday it will list the ACE Global AI ASIC exchange-traded fund (ETF) on October 22. The ETF will focus on ...
Oct 21, 2024 (Gmt+09:00)
-
Future mobility
South Korea to designate Jeju as flying taxi pilot service zone
South Korea will designate its resort island Jeju a test operation zone for flying taxis as part of the country’s national urban air mobility ...
Oct 15, 2024 (Gmt+09:00)
Latest News
- 1 BMW Surpasses Mercedes in Sales – Imported Car Market 'Shake-Up'
- 2 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 3 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 4 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 5 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google